Leukemia, Lymphoma, and Myeloma Program
Area of interest
My research interests involve clinical and translational research in the hematologic malignancies. In particular, I am involved in the design and conduct of phase I and II clinical trials of novel agents and drug combinations for patients with acute leukemias, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). Furthermore, I have particular interest in incorporating correlative science studies that can predict biologic response or drug toxicity in patients with hematologic cancers, including both host and tumor genetic variables that predict response to antileukemic agents.